Germany
Japan
United Kingdom
China
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 5G12-21
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Products
View as table Download
Mouse Monoclonal Mart-1 (Melan A) Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Mouse Monoclonal p53 Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
CD79a Mouse monoclonal Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthesized peptide derived from human CD79a |
Cytokeratin Mouse monoclonal Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthesized peptide derived from human Cytokeratin Pan |
MAGEC1 (8C5) Mouse monoclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Mucin 2 Mouse monoclonal Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthesized peptide derived from human MUC2 |
Mucin 4 Mouse monoclonal Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthesized peptide derived from human MUC4 |
Stathmin 1 (10D6) Mouse monoclonal Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 380.00
4 Weeks
Recombinant Anti-c-myc epitope tag (Clone 9E10)
| Applications | IF, IHC, IP, WB |
| Conjugation | Unconjugated |
Recombinant Anti-c-myc epitope tag (Clone 9E10)
| Applications | IF, IHC, IP, WB |
| Conjugation | Unconjugated |
Recombinant Anti-His tag (C-term) (Clone 3D5)
| Applications | ELISA, WB |
| Conjugation | Unconjugated |
Recombinant Anti-His tag (C-term) (Clone 3D5)
| Applications | ELISA, WB |
| Conjugation | Unconjugated |
Recombinant Anti-Fluorescein (Clone 4-4-20 (enhanced))
| Conjugation | Unconjugated |
| Modifications | This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. |
Recombinant Anti-Fluorescein (Clone 4-4-20 (enhanced))
| Conjugation | Unconjugated |
| Modifications | This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. |
USD 523.00
2 Weeks
Recombinant Anti-F4/80 (Clone Cl:A3-1 (recombinant version))
| Applications | FC, IHC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-CD16/CD32 (Clone 2.4G2)
| Applications | FC, IF, IHC, IP |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-CD52 (Clone Campath-1H)
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-V5 epitope tag (Clone SV5-P-K)
| Applications | ELISA, IF, IHC, IP, WB |
| Conjugation | Unconjugated |
Recombinant Anti-V5 epitope tag (Clone SV5-P-K)
| Applications | ELISA, IF, IHC, IP, WB |
| Conjugation | Unconjugated |
USD 675.00
2 Weeks
Recombinant Anti-CD11b (Clone 5C6 (recombinant version))
| Applications | IF, IHC |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Modifications | This constant region of this antibody has been modified to bind to Protein A, allowing highly-specific purification of this antibody by Protein A-affinity column. |
Recombinant Anti-CD2 (Clone YTH 655)
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD52 (Clone YTH 34.5-G2b (Campath-1G))
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
Recombinant Anti-CD8 alpha/Lyt-2 (Clone YTS 169.4)
| Applications | FC, IHC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
| Modifications | This is a chimeric antibody created to reduce immunogenicity during in vivo applications. |
USD 523.00
2 Weeks
Recombinant Anti-Unknown Specificity (Isotype control) (Clone MOPC-21)
| Conjugation | Unconjugated |
| Host | Mouse |
| Isotype | IgG2b, kappa |
USD 523.00
2 Weeks
Recombinant Anti-Unknown Specificity (Isotype control) (Clone MOPC-21)
| Conjugation | Unconjugated |
| Host | Rat |
| Isotype | IgG2b, kappa |
Recombinant Anti-Beta-2 microglobulin (Clone BBM.1)
| Applications | IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CCR3 (CD193) (Clone 5E8-G9-B4)
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-Complement Receptor 1 & 2 (Clone 7G6)
| Applications | FC, IHC, IP, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-CD7 (Clone 3A1E)
| Applications | FC, Func |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD73 (Clone YDBYT 208.3)
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-Human Muscle Acetylcholine Receptor (Clone mAb 192)
| Applications | Bl, ELISA, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Recombinant Anti-CD30 (Clone Ki-3)
| Applications | ELISA, FC, IF, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD8 beta (Clone YTS 156.7.7)
| Applications | FC, IHC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-GITR (Clone YGITR765)
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-Lymphotoxin alpha (Clone 3F12.2D3)
| Applications | ELISA, FC, Neutralize |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD74 (Clone In-1)
| Applications | FC, IHC, IP |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-MHC II (Clone P7/7)
| Applications | FC, IHC, IP |
| Reactivities | Mouse, Rat |
| Conjugation | Unconjugated |
Recombinant Anti-MHC I (Clone R1-21.2)
| Applications | IHC, IP, R |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Active filters
Isotypes
- IgG2b, kappa
Conjugates
- Unconjugated
Filter by
Target Symbol
- EBI3 (4)
- MAVS (3)
- CD1A (2)
- CD52 (2)
- ERBB2 (2)
- FITC (2)
- HIS (2)
- HSPB1 (2)
- IL17RA (2)
- MYC (2)
- SALL4 (2)
- TMBIM6 (2)
- V5 (2)
- ACP5 (1)
- ACTB (1)
- ADGRE1 (1)
- APIP (1)
- ARHGDIB (1)
- B2M (1)
- BRCA1 (1)
- CALD1 (1)
- CCR3 (1)
- CCR5 (1)
- CD16 (FCGR3A) (1)
- CD2 (1)
- CD226 (1)
- CD37 (1)
- CD7 (1)
- CD74 (1)
- CD79A (1)
- CD86 (1)
- CD8A (1)
- CD8B1 (1)
- CDKN1C (1)
- CHRNA1 (1)
- CIP2A (1)
- CLDN4 (1)
- CR2 (1)
- CRLF2 (1)
- CTLA4 (1)
- CXCR1 (1)
- CYCS (1)
- CYP8B1 (1)
- DDIT3 (1)
- EPCAM (1)
- FCGR2A (1)
- GABRA1 (1)
- GCG (1)
- GFAP (1)
- H3 (1)
- HIST3H3 (1)
- HMGB1 (1)
- HNRNPM (1)
- IGF2 (1)
- IL17A (1)
- IL27RA (1)
- IL2RG (1)
- IL6RA (1)
- IL9 (1)
- INS (1)
- ITGAM (1)
- KAT2B (1)
- KERATIN (1)
- LIF (1)
- LTA (1)
- MAGEC1 (1)
- MGST1 (1)
- MHC I (1)
- MHC II (1)
- MLANA (1)
- MSLN (1)
- MUC2 (1)
- MUC4 (1)
- NLRP3 (1)
- NT5E (1)
- PARP1 (1)
- PCLO (1)
- PHB (1)
- PRC1 (1)
- S (1)
- S100A8 (1)
- SARS (1)
- SF3B4 (1)
- SPN (1)
- SSRP1 (1)
- SST (1)
- STMN1 (1)
- TAOK1 (1)
- TIMP2 (1)
- TLR4 (1)
- TNFRSF8 (1)
- TNFSF18 (1)
- TNFSF8 (1)
- TP53 (1)
- TPO (1)
- TUBG1 (1)
- UBA6 (1)
- YWHAZ (1)
Reactivities
Applications
Antibody Hosts
Clonalities
Modifications
- This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. (4)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This constant region of this antibody has been modified to bind to Protein A, allowing highly-specific purification of this antibody by Protein A-affinity column. (1)
- This is a chimeric antibody created to reduce immunogenicity during in vivo applications. (1)
Assay Types
Families
Pathways
- Cytokine-cytokine receptor interaction (5)
- MAPK signaling pathway (5)
- Pathways in cancer (4)
- Bladder cancer (3)
- Cell cycle (3)
- Cytosolic DNA-sensing pathway (3)
- Endometrial cancer (3)
- Neurotrophin signaling pathway (3)
- Non-small cell lung cancer (3)
- Pancreatic cancer (3)
- Prostate cancer (3)
- RIG-I-like receptor signaling pathway (3)
- Adherens junction (2)
- Amyotrophic lateral sclerosis (ALS) (2)
- Apoptosis (2)
- Base excision repair (2)
- Calcium signaling pathway (2)
- Colorectal cancer (2)
- ErbB signaling pathway (2)
- Focal adhesion (2)
- Huntington's disease (2)
- Jak-STAT signaling pathway (2)
- Metabolic pathways (2)
- Pathogenic Escherichia coli infection (2)
- Small cell lung cancer (2)
- Spliceosome (2)
- Ubiquitin mediated proteolysis (2)
- VEGF signaling pathway (2)
- p53 signaling pathway (2)
- Alzheimer's disease (1)
- Aminoacyl-tRNA biosynthesis (1)
- Basal cell carcinoma (1)
- Chronic myeloid leukemia (1)
- Cysteine and methionine metabolism (1)
- Glioma (1)
- Lysosome (1)
- Melanoma (1)
- NOD-like receptor signaling pathway (1)
- Notch signaling pathway (1)
- Oocyte meiosis (1)
- PPAR signaling pathway (1)
- Parkinson's disease (1)
- Primary bile acid biosynthesis (1)
- Riboflavin metabolism (1)
- Systemic lupus erythematosus (1)
- Thyroid cancer (1)
- Toll-like receptor signaling pathway (1)
- Viral myocarditis (1)
- Wnt signaling pathway (1)